Dolthene 22.65 mg/ml Suspensie voor oraal gebruik
Dolthene 22.65 mg/ml Suspensie voor oraal gebruik
Not authorised
- Oxfendazole
Product identification
Medicine name:
Dolthene 22.65 mg/ml Suspensie voor oraal gebruik
Dolthene 22.65 mg/ml Suspension buvable
Dolthene 22.65 mg/ml Suspension zum Einnehmen
Active substance:
- Oxfendazole
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxfendazole2.27/gram(s)100.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC02
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Belgium
Package description:
- Dolthene 1 Bottle with 250 ml Oral suspension
- Dolthene 1 Bottle with 200 ml Oral suspension
- Dolthene 1 Bottle with 150 ml Oral suspension
- Dolthene 1 Bottle with 100 ml Oral suspension
- Dolthene 1 Bottle with 50 ml Oral suspension
- Dolthene 1 Bottle with 20 ml Oral suspension
- Dolthene 1 Bottle with 10 ml Oral suspension
- Dolthene 1 Bottle with 5 ml Oral suspension
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dopharma Research B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Dopharma Research B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V164717
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
